Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study

This study suggests that upadacitinib is a safe and effective treatment for moderate-to-severe AD in presence of tobacco smoke, with no significant differences in safety or effectiveness compared with patients who do not smoke.

Authors

Institutions

Publication Details

Journal
American Journal of Clinical Dermatology
Published
2025-02-24
DOI
https://doi.org/10.1007/s40257-025-00926-y
Citations
5
Primary Topic
Dermatology and Skin Diseases
Type
article
Field-Weighted Citation Impact
10.02

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study

Luca Mastorino, Martina Maurelli, Angelo Valerio Marzano, Simone Ribero et al.
5 citations
American Journal of Clinical Dermatology
Dermatology and Skin Diseases
10.02
article

Safety and Effectiveness of Upadacitinib in Patients with Moderate-to-Severe Atopic Dermatitis Who Smoke: a 2-Year Real-Life Multicenter Study

Luca Mastorino, Martina Maurelli, Angelo Valerio Marzano, Simone Ribero, Maddalena Napolitano, Luigi Gargiulo, Eugenia Veronica Di Brizzi, Giampiero Girolomoni, Andrea Chiricozzi, Mariateresa Rossi, Niccolò Gori, Claudia Paganini, Ruggero Cascio Ingurgio, Mario Bruno Guanti, Francesco Leo, Marco Galluzzo, Anna Balato, Benedetta Gallì, Michela Ortoncelli, Pietro Quaglino, Elena Pezzolo, Cataldo Patruno, Caterina Foti, Silvia Mariel Ferrucci, Alessandra Narcisi, Francesca Barei, Giuseppe Lauletta, Chiara Anna Fiasconaro, Marta Casale Alloa, Laura Grigolato
article en
5 citations

Abstract

This study suggests that upadacitinib is a safe and effective treatment for moderate-to-severe AD in presence of tobacco smoke, with no significant differences in safety or effectiveness compared with patients who do not smoke.

American Journal of Clinical DermatologyVol. 26(3)
Università Cattolica del Sacro Cuore (IT), University of Rome Tor Vergata (IT), University of Verona (IT), Humanitas University (IT), University of Milan (IT), University of Campania "Luigi Vanvitelli" (IT), Agostino Gemelli University Polyclinic (IT), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Magna Graecia University (IT), Ospedale Maggiore (IT), Azienda Ospedaliero-Universitaria di Modena (IT), Department of Medical Sciences (BY), Policlinico Tor Vergata (IT), Ospedale San Bortolo (IT), Istituti di Ricovero e Cura a Carattere Scientifico (IT), IRCCS Humanitas Research Hospital (IT), University of Turin (IT), University of Bari Aldo Moro (IT), University of Naples Federico II (IT), University of Brescia (IT)
Università degli Studi di Torino
Good health and well-being
Openalex Percentile: Top 2%
Dermatology and Skin Diseases
10.02
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.